Saamya Biotech Limited Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2015
Saamya Biotech (India) Limited reported unaudited earnings results for the second quarter and six months ended September 30, 2015. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 76,707,236 against INR 0 a year ago. Profit from operations from other income, interest and exceptional items was INR 2,756,612 against INR 861,413 a year ago. Loss from ordinary activities before and after tax was INR 1,782,474 against INR 871,656 a year ago. Net loss for the period was INR 1,782,474 against INR 881,656 a year ago. Basic and diluted earnings per share were INR 0.07 against INR of 0.04 a year ago.
For the six months, the company reported net sales/income from operations (net of excise duty) of INR 144,021,942 against INR 0 a year ago. Profit from operations from other income, interest and exceptional items was INR 5,148,266 against INR 1,763,700 a year ago. Loss from ordinary activities before and after tax was INR 4,190,674 against INR 1,830,962 a year ago. Net loss for the period was INR 4,190,674 against INR 1,830,962 a year ago. Basic and diluted earnings per share were INR 0.17 against INR of 0.07 a year ago.